Affordable Weight-Loss Drugs for Medicare Patients

November eleventh brings a game-changing shift in pharmaceutical policy, making key weight-loss medications more affordable for Medicare and Medicaid patients. The new Most-Favored-Nation pricing links US drug costs to those in other wealthy nations, reducing prices for drugs like Ozempic and Wegovy. Industry leaders, including Mark Cuban and Currax CEO George Hampton, praise these reforms, expecting broader access and affordability for patients with obesity and related health conditions. DNN | The Daily News Now! The world’s first global local news network. Every city. Every story. AI powered. Hosted on Acast. See acast.com/privacy for more information.